大肠癌肝转移的相关因素及手术治疗效果的回顾性分析

doi:10.3877/cma.j.issn.2095-3224.2017.03.016

目的

探讨大肠癌肝转移的相关因素及手术治疗效果。

方法

回顾分析北京中医医院2010年1月至2015年12月间30例大肠癌肝转移患者的手术治疗和非手术治疗的效果，并选同期30例大肠癌非肝转移患者为对照，分析影响大肠癌肝转移的危险因素；采用Kaplan-Meier法对大肠癌肝转移患者进行生存分析并绘制生存曲线，采用log rank检验对手术与非手术治疗的生存曲线进行比较。

结果

大肠癌肝转移患者中，肿瘤大于5 cm（Χ²=4.344，P<0.05）及发生脉管癌栓（Χ²=4.593，P<0.05）的患者数量明显多于非肝转移患者；肝转移患者中，手术组和保守组中位生存时间分别是（37.200±4.857）月和（20.333±4.722）月，另外log rank检验得出：手术组五年累积生存率明显高于保守组（P=0.045）。

结论

肿瘤大小、脉管癌栓是大肠癌发生肝转移的危险因素，对大肠癌肝转移患者实施手术治疗可提高患者短期生存率。

关键词: 结直肠肿瘤, 肿瘤转移, 回顾性分析

Objective

To explore the related factors and the effect of surgical treatment for colorectal cancer patients with liver metastasis.

Methods

Retrospective analysis the surgical and non-surgical treatment for 30 cases of patients with colorectal liver metastases from January 2010 to December 2015, and chose the colorectal cancer patients without liver metastases at the same period as the control group, and then, analysis the risk factors of colorectal liver metastases. To use the Kaplan-Meier method to analyze the accumulation survival rate for colorectal cancer patients with liver metastasis and to draw the cumulative survival curve, thus, to compare the cumulative survival curve of surgical and non-surgical treatment through the log rank test.

Results

The number of patients whose tumor size were greater than 5 cm and suffered with vascular tumor emboli among colorectal cancer patients with liver metastasis were more than colorectal cancer patients without liver metastasis (Χ²=4.344, Χ²=4.593, all P<0.05). Among these patients with liver metastasis, the median survival time of surgical group and conservative group were (7.200±4.857) months and (20.333±4.722) months respectively. And the log rank test showed that the 5-year cumulative survival rate of the surgical groups was significantly higher than that of the conservative group (P=0.045).

Conclusion

Tumor size and vascular tumor emboli are the risk factors for colorectal cancer patients with liver metastases, and the therapy of surgical treatment can improve the short-term survival rate for them.

Key words: Colorectal neoplasms, Neoplasm metastasis, Retrospective analysis

表1 结肠癌患者发生肝转移的单因素分析［例（%）］

组别	例数	肿瘤大小		肿瘤分化程度				脉管癌栓
组别	例数	1~5 cm	>5 cm	G1	G2	G3	G4	脉管癌栓
肝转移组	30	17	13	13	5	8	7	15
非肝转移组	30	9	21	10	7	6	7	7
X²值	?	?	4.344	0.635	?	?	?	4.593
P值	?	?	0.037	0.462	?	?	?	0.032

表1 结肠癌患者发生肝转移的单因素分析［例（%）］

组别	例数	肿瘤大小		肿瘤分化程度				脉管癌栓
组别	例数	1~5 cm	>5 cm	G1	G2	G3	G4	脉管癌栓
肝转移组	30	17	13	13	5	8	7	15
非肝转移组	30	9	21	10	7	6	7	7
X²值	?	?	4.344	0.635	?	?	?	4.593
P值	?	?	0.037	0.462	?	?	?	0.032

图1 大结肠癌肝转移手术治疗与非手术治疗患者的累积生存曲线

[1]	汤钊猷.现代肿瘤学 [M]. 第2版.上海:上海医科大学出版社, 2000: 775-818.
[2]	NCCN. Clinical practice guidelines in Oncology: colon cancer（2016.V2）[EB/OL]. NCCN, 2015[2015-11-24]. URL
[3]	Zalinski S, Mariette C, Farges O, et al. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version [J]. J Visc Surg, 2011, 148(3):e171-182.
[4]	Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results [J]. Eur J Cancer, 2002, 38(7):1023-1033.
[5]	施东华, 王小林. 大肠癌肝转移机制及诊治进展 [J]. 中国医学计算机成像杂志, 2010, 16(1):81-86.
[6]	郁宝铭.结直肠癌肝转移的外科防治 [J]. 腹部外科, 2000, 13(1): 22-24.
[7]	Dexiang Z, Li R, Ye W, et al. Outcome of patients with colorectal liver metastasis: analysis of 1, 613 consecutive cases [J]. Ann Surg Oncol, 2012, 19(9):2860-2868.
[8]	朱德祥, 任黎, 许剑民.不可切除结直肠癌肝转移的转化性治疗策略 [J]. 中国实用外科杂志, 2013, 33(8):635-644.
[9]	Bolton JS, Fuhman GM.Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [J]. Ann Sury, 2000, 231 (5):743-751.
[10]	Lochan R, White SA, Manas DM. Liver resection for colorectal liver metastasis [J]. Surg Oncol, 2007, 16 (1):33-45.
[11]	邱云峰, 许海民, 陈虹, 等.大肠癌肝转移的诊断及外科治疗(附32例报告) [J]. 中国医师进修杂志, 2006, 29(11):40-41, 43.
[12]	谭桂兴.大肠癌肝转移的诊断与治疗 [J]. 中华现代医学与临床, 2007, 6(6):20-21.
[13]	Adam R, Hoti E, Folprecht G, et al. Accomplishments in 2008 in the management of curable metastatic colorectal cancer [J]. Gastrointest Cancer Res, 2009, 3(5 Supplement 2):S15-22.
[14]	Zalinski S, Mariette C, Farges O, et al. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version [J]. J Visc Surg, 2011, 148(3):e171-182.
[15]	Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy [J]. J Clin Oncol, 2009, 27(22):3677-3683.
[16]	中华人民共和国卫生和计划生育委员会医政医管局, 中华医学会肿瘤学分会. 结直肠癌诊疗规范(2015年版) [J]. 中华外科杂志, 2015, 53(12):881-894.
[17]	罗威等. 结肠癌同时性肝转移同期手术与分期手术的疗效比较 [J]. 中国普通外科杂志, 2013, 22(4):434-437.
[18]	王庆新, 徐斌, 晏建军, 等.同时性结直肠癌肝转移患者治疗策略探讨 [J]. 癌症, 2008, 27 (7):748-751.
[19]	Andreou A, Aloia TA, Brouquet A, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastasesin the era of modern chemotherapy [J]. Ann Surg, 2013, 257(6):1079-1088.
[20]	Angelsen JH, Horn A, Eide GE, et al. Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival [J]. World J Surg Oncol, 2014, 12:127.
[21]	Mise Y, Kopetz S, Mehran RJ, et al. Is complete liver resection without resection of synchronous lung metastases justified? [J]. Ann Surg Oncol, 2015, 22(5):1585-1592.
[22]	Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma [J]. J Hepatol, 2003, 39(6):888-895.
[23]	Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry [J]. Ann Surg, 2014, 260(5):829-836.
[24]	王征, 樊嘉, 周俭.ALPPS在肝脏外科的应用前景 [J]. 肝胆外科杂志, 2015, 23(1):1-2.

[1]	康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2]	代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3]	王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4]	唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5]	张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6]	晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[7]	李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8]	倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[9]	范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[10]	关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[11]	顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[12]	黄怡诚, 陆晨, 孙司正, 喻春钊. 肝特异性转录因子FOXA2在人结直肠癌肝转移阶梯模型中的表达变化及其意义[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 396-403.
[13]	刘祺, 张凯, 李建男, 刘铜军. 结直肠癌肝转移生物治疗的现状及进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 415-419.
[14]	吴寅, 陈智琴, 高勇, 权明. Her-2阳性结直肠癌的诊治进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 420-425.
[15]	孙昕, 程海波, 沈卫星. 基于全转录组学探讨仙连解毒方治疗Ⅲ期结直肠癌患者的疗效机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 277-283.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

A retrospective analysis of the related factors and effect of surgical treatment for colorectal cancer patients with liver metastasis

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

A retrospective analysis of the related factors and effect of surgical treatment for colorectal cancer patients with liver metastasis